CD56-positive diffuse large B-cell lymphoma/leukemia with BCL6/MYC double-hit and multiple gene mutations: an indicator of poor prognosis?
Y Liu, J Shen, M Awal Issah, T Liu… - Journal of …, 2020 - journals.sagepub.com
Diffuse large B-cell lymphoma (DLBCL) is the most common adult non-Hodgkin lymphoma
(NHL) and is highly invasive, with a poor prognosis. The main clinical treatment for DLBCL …
(NHL) and is highly invasive, with a poor prognosis. The main clinical treatment for DLBCL …
[HTML][HTML] CD56-positive diffuse large B-cell lymphoma/leukemia with BCL6/MYC double-hit and multiple gene mutations: an indicator of poor prognosis?
Y Liu, J Shen, MA Issah, T Liu, H Zhou… - The Journal of …, 2020 - ncbi.nlm.nih.gov
Diffuse large B-cell lymphoma (DLBCL) is the most common adult non-Hodgkin lymphoma
(NHL) and is highly invasive, with a poor prognosis. The main clinical treatment for DLBCL …
(NHL) and is highly invasive, with a poor prognosis. The main clinical treatment for DLBCL …
[PDF][PDF] CD56-positive diffuse large B-cell lymphoma/leukemia with BCL6/MYC double-hit and multiple gene mutations: an indicator of poor prognosis?
Y Liu, J Shen, MA Issah, T Liu, H Zhou, H Fu - Journal of International … - academia.edu
Diffuse large B-cell lymphoma (DLBCL) is the most common adult non-Hodgkin lymphoma
(NHL) and is highly invasive, with a poor prognosis. The main clinical treatment for DLBCL …
(NHL) and is highly invasive, with a poor prognosis. The main clinical treatment for DLBCL …
CD56-positive diffuse large B-cell lymphoma/leukemia with BCL6/MYC double-hit and multiple gene mutations: an indicator of poor prognosis?
Y Liu, J Shen, T Liu, H Zhou, H Fu - The Journal of International …, 2020 - europepmc.org
Diffuse large B-cell lymphoma (DLBCL) is the most common adult non-Hodgkin lymphoma
(NHL) and is highly invasive, with a poor prognosis. The main clinical treatment for DLBCL …
(NHL) and is highly invasive, with a poor prognosis. The main clinical treatment for DLBCL …
CD56-positive diffuse large B-cell lymphoma/leukemia with BCL6/MYC double-hit and multiple gene mutations: an indicator of poor prognosis?
Y Liu, J Shen, MA Issah, T Liu… - The Journal of …, 2020 - pubmed.ncbi.nlm.nih.gov
Diffuse large B-cell lymphoma (DLBCL) is the most common adult non-Hodgkin lymphoma
(NHL) and is highly invasive, with a poor prognosis. The main clinical treatment for DLBCL …
(NHL) and is highly invasive, with a poor prognosis. The main clinical treatment for DLBCL …